Moderna Inc (MRNA)
Gross profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | -390,000 | 1,672,000 | 4,543,000 | 8,419,000 | 12,435,000 | 15,793,000 | 17,886,000 | 18,212,000 | 15,098,000 | 9,710,764 | 5,740,765 | 2,287,382 | 604,584 | 136,875 | 16,732 | -28,325 | -23,785 | -2,419 |
Revenue (ttm) | US$ in thousands | 6,758,000 | 9,088,000 | 10,654,000 | 15,059,000 | 19,263,000 | 21,390,000 | 22,995,000 | 22,600,000 | 18,471,000 | 11,831,000 | 7,019,000 | 2,732,000 | 803,000 | 246,055 | 106,101 | 52,184 | 60,209 | 81,575 |
Gross profit margin | -5.77% | 18.40% | 42.64% | 55.91% | 64.55% | 73.83% | 77.78% | 80.58% | 81.74% | 82.08% | 81.79% | 83.73% | 75.29% | 55.63% | 15.77% | -54.28% | -39.50% | -2.97% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-390,000K ÷ $6,758,000K
= -5.77%
The gross profit margin of Moderna Inc has displayed a decreasing trend over the past eight quarters. Starting at a high level of 84.77% in Q1 2022, the margin has steadily declined to 31.47% in Q4 2023. This suggests that Moderna Inc's cost of goods sold has been increasing relative to its revenue generation. The significant drop in the gross profit margin from Q1 2022 to Q4 2023 indicates a potential challenge in maintaining profitability and cost efficiency in the company's operations. Further analysis into the factors influencing these changes would be necessary to understand the underlying causes and implications for Moderna Inc's financial performance.
Peer comparison
Dec 31, 2023